Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularization
- 27 October 2009
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Biological Therapy
- Vol. 10 (1), 57-71
- https://doi.org/10.1517/14712590903379510
Abstract
Importance of the field: Regulating stem cell contributions to vascularization is a challenging goal, but a fundamental aspect of regenerative medicine. Human mesenchymal stem cells retain considerable potential for adult vascular repair and regeneration therapies. They are readily obtained, rapidly proliferate in culture, display a capacity to differentiate towards endothelial or vascular smooth muscle cells, and play an important role in postnatal neovascularization in various tissue contexts. To therapeutically enhance neovascularization during ischemic disease, or inhibit neovascularization during tumorigenesis, an essential prerequisite is to determine the mechanisms which control the recruitment and differentiation of mesenchymal stem cells towards vascular cells. Areas covered in this review: In this review, we describe the current understanding of how PDGF receptors contribute prominently to neovascularization, and play a decisive role in modulating mesenchymal stem cell recruitment and differentiation towards vascular cells. We discuss PDGF receptor-based therapeutic strategies to exploit mesenchymal stem cells during vascular repair and regeneration, and to control pathological neovascularization. Take home message: PDGF receptor signaling is emerging as a critical regulatory mechanism and important therapeutic target, that critically directs the fate of mesenchymal stem cells during postnatal neovascularization.This publication has 94 references indexed in Scilit:
- Regulation of Platelet-derived Growth Factor Receptor Function by Integrin-associated Cell Surface TransglutaminaseOnline Journal of Public Health Informatics, 2009
- Endothelial differentiation of Wharton's jelly–derived mesenchymal stem cells in comparison with bone marrow–derived mesenchymal stem cellsExperimental Hematology, 2009
- Mesenchymal Stem Cells Can Participate in Ischemic NeovascularizationPlastic and Reconstructive Surgery, 2009
- Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: Prediction of microRNA regulation by PDGF during osteogenesisExperimental Hematology, 2008
- VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinomaBritish Journal of Cancer, 2008
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- The role of oxygen availability in embryonic development and stem cell functionNature Reviews Molecular Cell Biology, 2008
- Fibulin-5 binds human smooth-muscle cells through α5β1 and α4β1 integrins, but does not support receptor activationBiochemical Journal, 2007
- Vascular endothelial growth factor can signal through platelet-derived growth factor receptorsThe Journal of cell biology, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006